Editorial Picks
Hand-picked stories offering depth, insight, and perspective on global cannabis developments.
Editorial Picks · page 3
- Patient Access
‘Everything in Our Power’: German Patient Groups Fight to Overturn Cannabis Insurance Cuts
Earlier this month (July 10, 2026), the German government voted through a sweeping set of provisions set to significantly impact medical cannabis patients who have their prescriptions covered by their statutory health insurance.
- Clinical Research
A Cannabis Flavonoid Stopped Up to 99% of Cancer-Cell Growth in Lab Tests
Standard Seed Corporation (SSC), a cutting edge AI botanical-research company, believes it has identified a compound native to cannabis which could inhibit the growth of cancer cells by over 90% in some of the most aggressive forms of cancer.
- Medical Cannabis
Cannabis Use Among Teens Flat After German Partial Legalisation, But Medical Market Continues Rapid Expansion
Germany’s Cannabis Act (CanG) has not led to an increase in use among young people, according to new peer-reviewed research adding to the growing body of evidence contradicting the harms predicted by the reform’s critics.
- US & Canada
DEA Rescheduling Hearing Closes as States’ Own Witness Concedes Regulation Reduces Crime
The Drug Enforcement Administration’s (DEA) administrative hearing on cannabis rescheduling saw both sides make their closing arguments on Wednesday, July 15, bringing the 17-day proceedings to a broadly positive close.
- US & Canada
US Rescheduling Hearing Nears End as Opposition’s Own Witness Acknowledges Cannabis Fits Schedule III Standard
Tomorrow (July 15, 2026) the landmark administrative hearing on US cannabis rescheduling will come to a close.
- Pharmaceutical
World’s Largest CBD Insomnia Trial Could Hand Avecho an Australian Monopoly
The world’s largest clinical trial on cannabidiol (CBD) as a treatment for insomnia has been given the green light to complete its Phase III trial, transforming the fortunes of Avecho Biotechnology, and potentially the lives of insomnia sufferers worldwide.
- Patient Access
Germany Bans Cannabis Flowers from GKV and Mandates Six-Month Trial for Extracts
Germany has today voted to ban medical cannabis flower from its statutory health insurance scheme, in a controversial move critics say will have an outsized impact on the ‘seriously ill’.
- Cultivation
‘No Right to GMP Washing’: German State Challenges Cannabis Flower Import Compliance
Authorities from the German state of Hesse have taken aim at the practice of ‘GMP washing’ in its thriving medical cannabis market, an intervention that could have significant implications for the industry at large.
- Cultivation
EU Medical Cannabis Faces Its Most Consequential Regulatory Overhaul
Cultivation is perhaps the most complex, highly regulated, and expensive part of the cannabis supply chain.
- Medical Cannabis
France Breaks Medical Cannabis Deadlock as Reimbursement Decree Filed for Legal Review
France’s incoming generalised medical cannabis framework has edged tantalisingly close to clearing its last remaining hurdle, as the outstanding decree governing the reimbursement of cannabis medicines has been submitted to France’s highest administrative court.
- Interviews
Green Rush to Grown Up: Cannabis Investment No Longer Needs Hype
Investment in the cannabis industry has long been dominated by specialists, speculators, and momentum traders, but that is beginning to change.
- UK & Europe
Ireland’s Cross-Party Drug Committee Calls for Full Decriminalisation. The Government Has Already Said No
Ireland’s Oireachtas Joint Committee on Drugs Use has recommended the full decriminalisation of personal possession of all drugs, calling on the government to repeal Section 3 of the Misuse of Drugs Act 1977.
